The treatment with corticosteroids in refractory septic shock has historically been of great controversy, taking into account the heterogeneous results found in the different randomized clinical trials. However, in light of the current evidence, it is recognized that, despite not having a significant impact on mortality, it has benefits by reducing the duration of shock, the use of vasopressors, the stay in the intensive care unit and in the days of mechanical ventilation. Methodology: a narrative review about corticosteroids in septic shock was carried out, through a systematic search in PubMed, Medline, Cochrane, and RIMA, for articles in English and Spanish, from January 1, 1980 to August 1, 2021 taking as keywords septic shock, systemic inflammatory response syndrome, corticosteroids.
María Monterrosa-Robles1*, Candelaria Cortazar-Barreto2, Yuranis Navarro-Alvarez3, Fabio Pérez-
Contreras4, Fabio Salas-De la Hoz5